Han Returns to Kantar Health China

Hettie Han has rejoined Kantar Health China as Director in Beijing, from where she will work alongside the global team to grow the firm's multi-client and consultancy business across the region.

Han (pictured) was Director of Healthcare Research at the division before leaving to work as a Director at healthcare market research and forecasting specialist TBL Consulting. Earlier in her career, she held analyst roles at several US and China-based pharma companies, including working as Global Oncology Market Research Manager at Bristol-Myers Squibb. She also worked for Penwest Pharmaceuticals and Kunming Pharmaceuticals.

Simon Li, General Manager Kantar Health China, comments: 'During her previous tenure with us, Hettie was instrumental in building our business in this key market for the healthcare industry. She has deep experience across a variety of therapeutic areas and has proven herself to be a trusted adviser to her pharma-industry clients, from recognizing their business issues to collaborating with them to provide the right solutions.'

Web site: www.kantarhealth.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Kantar Health
• All news